[Chronic viral hepatitis--one of the most important problems of current medicine]

Arkhiv Patologii
|January 15, 2005
PubMed

Insights

This study examines chronic viral hepatitis caused by Hepatitis B (HBV) and C (HCV) viruses, including liver disease and extrahepatic manifestations. A generalized infection hypothesis leads to a proposed integrated treatment approach.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Chronic viral hepatitis, particularly from Hepatitis B (HBV) and Hepatitis C (HCV) infections, presents complex clinical and morphological challenges.
  • Understanding the clinico-morphological characteristics and prognosis of chronic liver diseases (CLD) is crucial for effective patient management.
  • Extrahepatic manifestations associated with HBV and HCV infections require careful consideration in diagnosis and treatment.

Purpose:

  • To explore the clinico-morphological features and prognosis of chronic liver diseases (CLD) caused by HBV and HCV.
  • To characterize extrahepatic lesions associated with HBV and HCV infections.
  • To investigate features of CLD with mixed viral and alcoholic etiology and propose a comprehensive treatment approach for chronic viral hepatitis, including its extrahepatic manifestations.

Summary:

  • The study reviews key aspects of chronic viral infections, focusing on HBV and HCV.
  • It examines clinico-morphological characteristics, prognosis, and extrahepatic lesions of chronic liver diseases (CLD).
  • A hypothesis on the generalized nature of HBV and HCV infection is proposed, leading to an integrated treatment strategy for chronic viral hepatitis and associated extrahepatic manifestations.

Impact:

  • This research contributes to a better understanding of the generalized nature of HBV and HCV infections.
  • It proposes a novel, integrated treatment approach for chronic viral hepatitis, addressing both liver and extrahepatic manifestations.
  • The findings aim to improve patient outcomes and management strategies for individuals suffering from chronic viral liver diseases.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...